Concepedia

J. Desai

JD

Statistics

Publications

1

Citations

13

H-Index

1

Active since

2022

Affiliations

Vanderbilt-Ingram Cancer Center(Current)

J. Desai is an author at Vanderbilt-Ingram Cancer Center specializing in cancer pharmacology, anticancer mechanism of action, and oncology.

Publications per year

2022–2022

1

Publications

1

LBA26 BREAKWATER safety lead-in (SLI): Encorafenib (E) + cetuximab (C) + chemotherapy (chemo) for BRAFV600E metastatic colorectal cancer (mCRC)

Josep Tabernero, T. Yoshino, T.W. Kim et al. · Annals of Oncology · 2022 · 13 citations

, , +11

1–1 of 1